mefruside
{{Short description|Chemical compound}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 444450342
| IUPAC_name = 4-chloro-N1-methyl-N1-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide
| image = Mefruside.png
| tradename =
| Drugs.com = {{drugs.com|international|mefruside}}
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status = Rx-only
| routes_of_administration = Oral
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 7195-27-9
| ATC_prefix = C03
| ATC_suffix = BA05
| ATC_supplemental =
| PubChem = 4047
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = X1NS9SNS92
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01877
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 3907
| chemical_formula =
| C=13 | H=19 | Cl=1 | N=2 | O=5 | S=2
| smiles = CC1(CCCO1)CN(C)S(=O)(=O)C2=CC(=C(C=C2)Cl)S(=O)(=O)N
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C13H19ClN2O5S2/c1-13(6-3-7-21-13)9-16(2)23(19,20)10-4-5-11(14)12(8-10)22(15,17)18/h4-5,8H,3,6-7,9H2,1-2H3,(H2,15,17,18)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = SMNOERSLNYGGOU-UHFFFAOYSA-N
}}
Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.{{cite journal |vauthors=Allen HB, Lee DA |title=A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension |journal=Curr Med Res Opin |volume=1 |issue=9 |pages=547–53 |year=1973 |pmid=4779251 |doi= 10.1185/03007997309111720}}
It was developed by Bayer A.G. and is sold under the tradename Baycaron.